Table 2.

Relative percentage (%) inhibition of TBARS, compared to the non-treated control.

Trial	Treatments	Incubation	Silage
1	0% NaCl (5:1 ratio); 30 s	−162.77	19.16
	0.9% NaCl (5:1 ratio); 30 s	−233.19	5.89
	3.0% NaCl (5:1 ratio); 30 s	−68.54	−0.83
	0% NaCl (5:1 ratio); 2 h	−217.78	6.06
	0.9% NaCl (5:1 ratio); 2 h	−204.00	8.85
	3.0% NaCl (5:1 ratio); 2 h	−1852.74	14.91
2	Tap water (5:1 ratio); 20 min	−28.99	10.26
	0.9% NaCl in Tap water (5:1 ratio); 20 min	9.32	14.84
	5% MANC in Tap water (5:1 ratio); 20 min	79.50	70.95
	0.2% isoascorbic acid with 0.044% EDTA in 0.9% NaCl (5:1 ratio); 20 min	69.26	36.39
	0.2% isoascorbic acid with 0.044% EDTA in tap water (5:1 ratio); 20 min	68.23	34.21
3	Tap water (5:1 ratio); 20 min	15.07	24.69
	2% MANC in tap water (5:1 ratio); 20 min	89.14	98.53
	2% isoascorbic acid in tap water (5:1 ratio); 20 min	74.26	70.76
	2% MANC in tap water (5:1 ratio); 20 min; prolonged storage at 4 °C for 24 h	80.24	97.21
4	0.5% rosemary extract in 0.9% NaCl; 1st incubation (2:1 ratio); 30 s	30.75	93.07
	0.5% rosemary extract in 0.9% NaCl; 4th incubation (2:1 ratio); 30 s	14.65	91.66
	0.5% rosemary extract in 0.9% NaCl; 10th incubation (2:1 ratio); 30 s	10.95	88.26
	0.5% rosemary extract in 0.9% NaCl; 10th incubation (3:1 ratio); 30 s	74.76	89.01
	2% isoascorbic acid in 0.9% NaCl; 1st incubation (2:1 ratio); 30 s	80.61	68.56
	2% isoascorbic acid in 0.9% NaCl; 4th incubation (2:1 ratio); 30 s	68.07	34.69

Negative and positive values denote percentage increase and decrease, respectively, in TBARS values compared to the non-treated control.

MANC: Duralox MANC-213; 5:1, 2:1 and 3:1 refer to the solution to co-product ratios used in different treatments.